Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-22-028760

SVP, Chief Financial Officer gave up 14,817 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Coiante Scott M SVP, Chief Financial Officer 2022-02-25 Shares withheld for taxes −14,817 $1.74 $25,782 76,649 D
Loading xslF345X03/tm227953-2_4seq1.xml…